Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.73p
   
  • Change Today:
    -0.017p
  • 52 Week High: 11.80
  • 52 Week Low: 2.25
  • Currency: UK Pounds
  • Shares Issued: 1,067.83m
  • Volume: 1,281,567
  • Market Cap: £114.61m
  • Beta: 1.18

Latest Deals

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Director Shareholdings

Notifier Holding Value*
Hans-Peter Hasler 5,500,000 £590,333
Anders Lundstrom 575,000 £61,717

Major Shareholders

Notifier** Holding Value*
AOP Orphan Pharmaceuticals AG 158,070,394 £16,966,222
Nutrition-Wellness Venture SA 56,008,541 £6,011,583
Jupiter Fund Management plc 34,127,697 £3,663,039
MaRu AG 12,532,918 £1,345,200
JPMorgan Asset Management Holdings Inc. 6,238,846 £669,636
Universities Superannuation Scheme Ltd 5,067,985 £543,964
Spreadex Ltd 4,123,006 £442,536

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 10.73p
Change Today -0.017p
% Change -0.16 %
52 Week High 11.80
52 Week Low 2.25
Volume 1,281,567
Shares Issued 1,067.83m
Market Cap £114.61m
Beta 1.18

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 07-Jan-2026

Time Volume / Share Price
13:59 95,655 @ 10.45p
13:57 200,000 @ 10.40p
13:55 50,000 @ 10.50p
13:38 445 @ 10.33p
13:31 9,807 @ 10.33p

STX Key Personnel

CEO Anders Lundstrom

Top of Page